Since it has been clarified that acridone was metabolized to 2-OH-acridone in the kidneys, it can be presumed that renal impairment is accompanied by a decrease in the activity of acridonehydroxylase involved in the metabolism and by marked changes in the urinary excretion of 2-OH-acridone. On the basis of experiments designed to establish the relationship between acridone metabolism and renal function, the present author arrived at the following conclusions: 1) Acridone was administered to nephrectomized rabbits, and their organs and intestinal contents were examined for its metabolic products, but 2-OH-acridone was never perceived. Therefore it was confirmed that the formation of acridone to 2-OH-acridone by metabolism occurred in the kidneys alone. 2) The urinary excretion of acridone and 2-OH-acridone in rabbits given acridone by the intravenous route came to end in a short time. 3) Intravenous injection of acridone had no effects on the P. S. P.-excreting capacity of rabbits. 4) Acridone was administered to rabbits with experimental renal impairment due to various kidney-impairing agents, and the excretion of acridone and 2-OH-acridone in their 24-hour urine collections was determined. When compared with healthy rabbits, it is evident that there was a highly significant decrease in the amount of 2-OH-acridone. Speaking of experimental renal impairment, its extent cannot be expressed in numerical terms and therefore no detailed information is available regarding the extent. However, the foregoing results were observed to a particularly remarkable extent in rabbits with severe disturbance of the vascular system and proximal renal tubules. 5) Healthy male subjects were given acridone by mouth and their 24-hour urine collections were examined for its metabolic products. Quite similarly to rabbits, glucuronides and sulfides of 2-OH-acridone and acridone were detected in untreated urine and 2-OH-acridone and acridone in hydrolyzed urine. Accordingly, acridone metabolism was the same in man and rabbits. These metabolic products were completely excreted in the urine within 24 hours. From the above-mentioned results it can be postulated that the calculation of the concentration ratio between acridone and 2-OH-acridone in 24-hour acridone urine permits clinical testing for renal impairment.
View full abstract